"Remington-Davis is the most experienced, independent research center in Central Ohio. Founded in 1992, our reputation for excellence is built upon the contributions of many volunteers which have allowed us to successfully complete over 500 trials. Volunteers choose Remington-Davis because they recognize our commitment to their well-being. Patient safety is our primary concern. We work closely with our doctors to ensure proper medical management of each clinical trial volunteer. Volunteers trust us, and we have a responsibility to treat each patient with dignity and as an individual human being. We believe in providing our research volunteers with care and the information needed to make a well informed choice to participate in our studies."

During the past decade, Remington Davis Inc conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 30 clinical trials were completed, i.e. on average, 69.8% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 20 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Remington Davis Inc" #1 sponsor was "Pfizer" with 7 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 3 trials sponsored, "Mitsubishi Tanabe Pharma America Inc." with 3 trials sponsored and "Reata Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Remington Davis Inc" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Department of Health and Human Services" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Remington Davis Inc" are "Autosomal Dominant Polycystic Kidney" (3 trials), "Chronic Obstructive Pulmonary Disease" (3 trials), "Clostridium Difficile Infection" (3 trials), "HIV Infections" (3 trials) and "Alopecia Areata" (2 trials). Many other conditions were trialed in "Remington Davis Inc" in a lesser frequency.

Most popular intervention types in "Remington Davis Inc" are "Drug" (54 trials), "Biological" (6 trials), "Device" (5 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Vancomycin" (3 trials), "placebo" (3 trials), "BLU-5937" (2 trials) and "CTP-543" (2 trials). Other intervention names were less common.

The vast majority of trials in "Remington Davis Inc" are 62 trials for "All" genders.

Currently, there are NaN active trials in "Remington Davis Inc". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 45 completed trials in Remington Davis Inc, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Remington Davis Inc, 4 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".